INFECTIONS IN MYELODYSPLASTIC SYNDROME IN RELATION TO STAGE AND THERAPY by Giuseppe Leone, Livio Pagano, Livio Pagano

Subjects: Get full text

Decitabine promotes the differentiation of poorly differentiated gastric cancer cells and enhances the sensitivity of NK cell cytotoxicity via TNF-α by Man Lv, Yue Wang, Ziyin Yuan, Lina Zhai, Haroon Iqbal, Uzair Ur-Rehman, Xin Ning, Huiying Wei, Jun Xin, Zihui Jin, Zhou Yi, Baichuan Wang, Wangkai Chen, Run Xiao

Subjects: “…Decitabine…”
Get full text

Enhanced FOXO1 expression as a predictor of decitabine response and prolonged survival in high-risk myelodysplastic syndrome by Hong Liu, Zheng Zhang, Nanfang Huang, Feng Xu, Sida Zhao, Chunkang Chang

Subjects: Get full text

Inhibition of DNA methylation promotes breast tumor sensitivity to netrin‐1 interference by Mélodie Grandin, Pauline Mathot, Guillaume Devailly, Yannick Bidet, Akram Ghantous, Clementine Favrot, Benjamin Gibert, Nicolas Gadot, Isabelle Puisieux, Zdenko Herceg, Jean‐Guy Delcros, Agnès Bernet, Patrick Mehlen, Robert Dante

Subjects: Get full text

A drug repurposing screen identifies decitabine as an HSV-1 antiviral by Laura Bautista, Cody Sirimanotham, Jason Espinoza, Dillon Cheng, Savaş Tay, Nir Drayman

Subjects: Get full text

Advanced organoid models for targeting Kras-driven lung adenocarcinoma in drug discovery and combination therapy by İsa Taş, Ruben Jacobs, Juliane Albrecht, Sebastian A. Barrientos, Josephine Åberg, Wondossen Sime, Hans Brunnström, Helena Persson, Julhash U. Kazi, Ramin Massoumi

Subjects: Get full text

Hypomethylating therapy mitigates acute allograft rejection in a murine lung transplant model by Kristine M. Yarnoff, William N. Daccarett-Bojanini, Andres F. Villabona-Rueda, Manuel Sollmann, Franco R. D’Alessio, Jeffrey M. Dodd-o

Subjects: Get full text

Prognostic analysis according to European LeukemiaNet 2022 risk stratification for elderly patients with acute myeloid leukemia treated with decitabine by Mihee Kim, Seo-Yeon Ahn, TaeHyung Kim, Sung-Hoon Jung, Ga-Young Song, Deok-Hwan Yang, Je-Jung Lee, Mi Yeon Kim, Ju Heon Park, Myung-Geun Shin, Jae-Sook Ahn, Hyeoung-Joon Kim, Dennis Dong Hwan Kim

Subjects: Get full text

Treatment of Vietnamese patients diagnosed with myelodysplastic neoplasms: Practical experience in a developing country by Quang Hao Nguyen, Minh Phuong Vu, Ha Trang Kieu, Duc Binh Vu, Ha Thanh Nguyen, Quoc Khanh Bach

Subjects: Get full text

Low dose DNA methyltransferase inhibitors potentiate PARP inhibitors in homologous recombination repair deficient tumors by Romain Pacaud, Scott Thomas, Sibapriya Chaudhuri, Ann Lazar, Luika A. Timmerman, Pamela N. Munster

Subjects: Get full text

Decitabine regulates the resistance of HCC to sorafenib through demethylation by Miao Zhang, Xiaolei Zhou, Zhenzhen Li, TianYu Zhao, Yu Miao, Sen Liu, Qiaoqiao Han, Libo Wang, Yongdeng Xu, Tao Cui, Ze Wang, Xiulin Yi, Fengying Yan, Xiaoliang Wang

Subjects: Get full text

KMT2A degradation is observed in decitabine‐responsive acute lymphoblastic leukemia cells by Luisa Brock, Lina Benzien, Sandra Lange, Maja Huehns, Alexandra Runge, Catrin Roolf, Anett Sekora, Gudrun Knuebel, Hugo Murua Escobar, Christian Junghanss, Anna Richter

Subjects: Get full text

Mechanism of action of decitabine in treating acute lymphoblastic leukemia by Xiaohui Gao, Hui Zeng, Fei Sun, Xiaoyan Zhao, Haibing Wu, Minchao Yan, Yuan Li, Qinyan Fu, Gang Zhang

Subjects: “…decitabine…”
Get full text

Multi-Organ Adverse Reaction to Two Hypomethylating Agents: A Challenge in High-Risk Myelodysplastic Syndrome Treatment by Sofia Brites Alves, Francesca Pierdomenico

Subjects: Get full text

Effect of decitabine on PD-L2 methylation in whole blood of iodine-induced autoimmune thyroiditis rats by Baiming Jin, Yanbo Qi, Hong Chao, Xiaolei Yang, Hongjie Li, Siyuan Wan

Subjects: Get full text

Intensified conditioning containing decitabine versus standard myeloablative conditioning for adult patients with KMT2A-rearranged leukemia: a multicenter retrospective study by Zhongli Hu, Zinan Feng, Shiqi Liu, Hai He, Ying Dong, Zhiping Fan, Yiqing Li, Fen Huang, Na Xu, Can Liu, Yunxin Zeng, Ping Zhu, Ren Lin, Hua Jin, Xiong Zhang, Ruijuan Sun, Qifa Liu, Li Xuan

Subjects: “…Decitabine…”
Get full text

Hypomethylating Agents in Oncohematology by AD Shirin, OYu Baranova

Subjects: Get full text

Effect of hypomethylating agents on prognosis in acute myeloid leukemia patients treated with HAG priming: a systematic review and meta-analysis by Jun Li, Shuying Fu, Chunmei Ye

Subjects: Get full text

5-Aza-2′-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39... by Adrian Fehn, Adrian von Witzleben, Ayla Grages, Tsima Abou Kors, Jasmin Ezić, Annika C. Betzler, Cornelia Brunner, Patrick J. Schuler, Marie-Nicole Theodoraki, Thomas K. Hoffmann, Simon Laban

Subjects: Get full text

Decitabine co-operates with the IL-33/ST2 axis modifying the tumor microenvironment and improving the response to PD-1 blockade in melanoma by Francesco Noto, Jacopo Mancini, Adriana Rosa Gambardella, Christina Curcio, Adele De Ninno, Sara Andreone, Carla Buccione, Maria Teresa D’Urso, Daniele Macchia, Anna Maria Pacca, Massimo Spada, Luca Businaro, Claudia Afferni, Fabrizio Mattei, Giovanna Schiavoni

Subjects: Get full text